Protocol Number: 03-C-0189
- To find a safe dose of Tipifarnib (also known as R115777 or ZARNESTRA) to be given with radiation therapy in patients who are, and who are not, taking the following anti-seizure medications: Dilantin, Tegretol, Carbatrol, Trileptal, and Mysoline; - To determine the safety and side effects of Tipifarnib and radiation therapy when given to patients with glioma (a type of brain tumor); and, - To determine if gliomas shrink when Tipifarnib is given with radiation therapy. Current post-surgical treatment of malignant (cancerous) gliomas with chemotherapy is disappointing. This study will test whether the findings of a recent pilot study suggesting a possible beneficial effect of Tipifarnib in patients with recurrent malignant gliomas can be confirmed. Patients 18 years of age and older with glioblastoma multiforme who have not received prior radiation therapy to the brain or cytotoxic or non-cytotoxic experimental drug therapy against the brain tumor may be eligible for this study. Patients may have received corticosteroids, antiepileptics, pain killers, and other drugs to treat symptoms or prevent complications. Candidates will be screened with a physical examination, magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain, and routine laboratory tests. Participants will receive Tipifarnib twice a day by mouth for 21 days, followed by 7 days without drug. This regimen constitutes one treatment cycle. These 4-week cycles will be repeated as long as the patient's disease does not worsen and the side effects of treatment are acceptable. After beginning treatment with Tipifarnib, patients will receive standard radiation therapy for glioblastoma. Radiation therapy lasts approximately 6 weeks. During treatment with R115777 and radiation therapy, participants will be seen in the clinic once a week. After radiation is completed, they will be seen every 4 weeks. Blood will be drawn once a week during radiation therapy and once every 2 weeks after completing radiation therapy. Patients will also have periodic physical and neurologic examinations. Brain MRI or CT scans will be done at diagnosis, after surgery, 4 weeks after completion of radiation therapy, and then at 8-week intervals.
Search The Studies | Help | Questions |
Warren Grant Magnuson Clinical Center (CC) |
||